🇺🇸 FDA
Patent

US 9265742

Compositions and methods for treating inflammatory pain

granted A61KA61K31/19A61K31/192

Quick answer

US patent 9265742 (Compositions and methods for treating inflammatory pain) held by Infirst Healthcare Limited expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/196, A61K31/215